Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03202628 · COMPLETED
Trial details
- NCT number
- NCT03202628
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2021-04-13
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.